Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Achilles Therape last posted its earnings results on Thursday, April 3rd, 2025. The company reported $-0.46 earnings per share for the quarter, missing analysts' consensus estimates of $-0.36 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Achilles Therape has generated $-2 earnings per share over the last year ($-1.74 diluted earnings per share) and currently has a price-to-earnings ratio of -0.85. Achilles Therape has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | -$0.48 | N/A | $0 | $0 |
| 06/28/2024 | Q2 2024 | N/A | -$0.41 | N/A | $0 | $0 |
| 03/29/2024 | Q1 2024 | N/A | -$0.30 | N/A | N/A | $0 |
| 04/04/2024 | Q4 2023 | -$0.46 | -$0.47 | -0.01 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.42 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$0.42 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$0.44 | N/A | N/A | $0 |
| 03/07/2023 | Q4 2022 | -$0.42 | -$0.61 | -0.19 | N/A | $0 |
| 09/30/2022 | Q3 2022 | N/A | -$0.32 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.44 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.45 | N/A | N/A | $0 |
| 03/01/2022 | Q4 2021 | -$0.41 | -$0.64 | -0.23 | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.34 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.45 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$0.36 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$0.32 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | -$5.00 | N/A | N/A | $580.00 K |
| 06/30/2020 | Q2 2020 | N/A | -$4.17 | N/A | N/A | $0 |
| 03/31/2020 | Q1 2020 | N/A | -$3.18 | N/A | N/A | $0 |
| 01/30/2020 | Q4 2019 | N/A | -$6.30 | N/A | N/A | $0 |
The conference call for Achilles Therape's latest earnings report can be listened to online.
The conference call transcript for Achilles Therape's latest earnings report can be read online.
Achilles Therape (:ACHL) has a recorded net income of $-69,665,000.Achilles Therape has generated $-1.74 earnings per share over the last four quarters.
Achilles Therape (:ACHL) has a price-to-earnings ratio of -0.85 and price/earnings-to-growth ratio is -0.07.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED